CTI (new: Innosuisse) Project on APP

21 December 2016

The project constitutes a collaboration between Malcisbo and the following academic partners: Department of Swine Medicine, University of Zurich; Institute of Bacteriology, University of Berne; Institute of Virology and Immunology, Berne (IVI); Federal Technical University Zurich (ETH). Within this project immunogenicity and protection of Malcisbo`s novel carbohydrate-based APP vaccine will be evaluated.

Link to CTI R&D grants

Latest News

  • 26 November 2018

    VetBioNet grant

    Malcisbo wins a grant to perform an APP challenge trial in a BLS3 facility.

  • 25 January 2017

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)

  • 21 December 2016

    Malcisbo participates in a CTI-funded research project on the development of a vaccine against APP.